ECILC vs MEDTR Comparison
Price, market cap, valuation, profitability and leverage metrics of ECILC and MEDTR side by side.
If You Had Invested TRY 10,000
Metric Comparison
| Metric | ECILC | MEDTR | Sector median |
|---|---|---|---|
| Last price (TL) | 64.05 | 18.17 | 18.72 |
| Daily change | −6.50% | −6.34% | −5.97% |
| Market cap | TRY 43.9B | TRY 2.2B | TRY 4.3B |
| P/E | — | 66.43 | 17.25 |
| P/B | 0.68 | 0.69 | 1.08 |
| Dividend yield | 2.04% | 0.44% | 0.90% |
| Return on equity | −3.08% | 1.14% | 1.78% |
| Free float | 22.02% | 20.21% | 37.21% |
Popular Comparisons
Related Pages
About the ECILC vs MEDTR Comparison
Price, market cap, valuation multiples, profitability and leverage of ECILC (Eczacıbaşı İlaç) and MEDTR (Meditera Tibbi Malzeme) side by side as of Sep 28, 2026, 15:49. Of the 14 metrics compared, ECILC leads in 5 and MEDTR leads in 9.
Highlights: Daily change: MEDTR leads (−6.34% vs −6.50%). Market cap: ECILC leads (TRY 43.9B vs TRY 2.2B). P/B: ECILC leads (0.68 vs 0.69). EV/EBITDA: MEDTR leads (7.60 vs 165.19). EV/Sales: MEDTR leads (1.36 vs 9.35). Dividend yield: ECILC leads (2.04% vs 0.44%). Gross margin: ECILC leads (37.83% vs 33.71%). EBITDA margin (annual): ECILC leads (11.49% vs 3.58%).
Frequently Asked Questions
Is ECILC or MEDTR cheaper?
By P/E, Tie is cheaper (— vs 66.43); by P/B, ECILC trades at the lower multiple (0.68 vs 0.69).
Which is more profitable, ECILC or MEDTR?
Annual net margin is −20.86% for ECILC and 1.35% for MEDTR; return on equity is −3.08% for ECILC and 1.14% for MEDTR.
Which is more leveraged, ECILC or MEDTR?
The leverage ratio is 18.92 for ECILC and 15.79 for MEDTR; net debt/EBITDA is 1.37 for ECILC and — for MEDTR. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.